/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

PitchBook: AI startups developing medical note-taking apps raised $800M in 2024, compared to $390M in 2023, as Microsoft and others compete for market share

Investment in the apps has doubled as Big Tech and start-ups compete to grab share of market  —  Investment in artificial …

Financial Times Madhumita Murgia

Context & Ripple Effects

Healthcare AI had already led AI industries in deal activity, with healthcare AI startups raising $4.3B across 576 deals since 2013. The new funding concentration narrows that broad investment story to a specific clinical workflow: producing medical notes.

The contest also fits a wider financing pattern in which Microsoft, Google and Amazon supplied 66% of generative-AI startup funding in 2023. Big Tech’s presence makes medical note-taking a market where startup fundraising and platform competition are increasingly intertwined.

First-order effects

  • AI medical note-taking startups gain a substantially larger 2024 funding pool, giving them more capital to develop and sell against Microsoft and other tech companies.
  • Microsoft and its rivals face a better-funded startup field in a market where they are already competing for share.

Second-order effects

  • Competition for clinical customers is likely to put greater weight on product integration and distribution, rather than on model capability alone.
  • The rise in dedicated funding can draw more investor attention toward narrowly defined healthcare AI applications, extending a sector that had already been an active AI deal market.

Third-order effects

  • If this funding pattern persists, AI competition in healthcare may organize around ownership of high-frequency clinician workflows, with large platforms and specialized vendors contesting the same entry points.
  • The market’s durability will depend on whether heavily funded products establish lasting adoption; fundraising alone does not determine which suppliers retain share.

The trend: Generative-AI investment is moving from broad platform bets toward capital-intensive contests for specific, repeatable enterprise workflows.

Discussion

  • @petetrainor.fyi Pete Trainor on bluesky
    Not sure what the market for these is like outside of the U.K., but here the NHS is so bogged down in red-tape that the likelihood of anybody succeeding is almost zero.  —  There'll be a contract awarded to maybe one product linked to a major supplier like Microsoft or IBM, but a…